Search Results
Mar 24, 2026, 15:24 ET Memesan Tes Laboratorium ESR dan CRP Sekaligus Dapat Menghemat Jutaan Dolar Setiap Tahun Bagi Rumah Sakit -- Penelitian Baru Ini Menentang Anggapan Bahwa Keduanya Dapat Saling Menggantikan
mencegah tes lanjutan yang tidak perlu.Tentang Penelitian IniKutipan: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests." ClinicoEconomics and Outcomes
More news about: Alcor Scientific
Mar 24, 2026, 15:16 ET /C O R R E C T I O N -- Forward Advantage/
More news about: Forward Advantage
Mar 24, 2026, 15:15 ET Continuity BiosciencesとBreakthrough T1D、NICHE®細胞療法プラットフォームのヒト初回臨床試験に向けて協業
この取り組みは、Breakthrough T1DのIndustry Discovery and Development Partnership（IDDP）プログラムを通じて支援されています。このプログラムは、T1Dの治療、治癒、予防に向けた有望な治療プログラムの加速を目的とする研究プロジェクトに資金を提供するものです。成功すれば、NICHEプラットフォームは、全身免疫抑制を最小限に抑えつつ、細胞移植片の直接的な血管化と局所的な免疫保護を可能にすることで、T1Dにおける細胞ベース治療の新たな送達パラダイムとなる可能性があります。この提携により、埋め込み型の精密制御薬物送達システムに関するContinuityの専門性と、T1Dエコシステム全体のイノベーションを加速するBreakthrough
More news about: Continuity Biosciences LLC
Mar 24, 2026, 14:57 ET Continuity Biosciences 與 Breakthrough T1D 攜手推進 NICHE® 細胞治療平台邁向首次人體臨床研究
Breakthrough T1D 的行業探索與開發合作夥伴關係 (Industry Discovery and Development Partnership, IDDP) 計劃支持，該計劃旨在資助研究項目，加快推進具潛力的治療方案，以促進一型糖尿病的治療、治癒及預防。若項目成功，NICHE 平台有望為一型糖尿病的細胞療法帶來嶄新的遞送模式，透過實現細胞直接血管生成及局部免疫保護，同時將全身免疫抑制的需求降至最低。是次合作結合了 Continuity 在可植入式、精準控制藥物遞送系統方面的專業技術，以及 Breakthrough T1D 在推動一型糖尿病 (T1D) 生態系統創新方面的全球領導地位。
More news about: Continuity Biosciences LLC
Mar 24, 2026, 14:46 ET UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
contact UCB:Investor Relations Antje Witte T +32.2.559.94.14 email [email protected] Yazdian T +32.2.559.91.37 email
More news about: UCB
Mar 24, 2026, 14:39 ET /C O R R E C T I O N -- Beacon Pointe Advisors/
More news about: Beacon Pointe Advisors
Mar 24, 2026, 14:25 ET A Continuity Biosciences e a Breakthrough T1D fazem parceria para levar adiante a plataforma de terapia celular NICHE® rumo ao primeiro estudo em seres humanos
que possam, um dia, levar à cura do diabetes tipo 1 é uma prioridade fundamental para a Breakthrough T1D", afirmou Asja Guzman, PhD, diretora associada de pesquisa em terapia celular da Breakthrough T1D. "A rejeição imunológica após o transplante continua a ser um desafio. Estamos entusiasmados em trabalhar
More news about: Continuity Biosciences LLC
Mar 24, 2026, 14:23 ET Continuity Biosciences y Breakthrough T1D anuncian colaboración para impulsar la plataforma de terapia celular NICHE® hacia el primer estudio en humanos
algún día puedan conducir a curas para la diabetes tipo 1 es una prioridad clave para Breakthrough T1D", señaló Asja Guzman, PhD, directora asociada de Investigación de Terapia Celular de Breakthrough T1D. "Abordar el rechazo inmunológico después del trasplante sigue siendo un desafío. Nos entusiasma colaborar
More news about: Continuity Biosciences LLC
Mar 24, 2026, 13:51 ET Province of La Rioja Bondholders Seek Seizure of the Shares in Banco Rioja and PEA in Satisfaction of their Outstanding Judgments Against the Province
LLPDennis Hranitzky in Salt Lake City and New YorkT +1-801-515-7333 [email protected] Loomis in BostonT +617-712-7309
More news about: Ad Hoc Committee of Province of La Rioja Bondholders
Mar 24, 2026, 13:49 ET American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
[email protected] Saad R, Lillaney P, Profant DA, Fuller DS, Poole EM, Alvord T, Prince P, Desai S, Whalen M, Ni W, Black J. Cardiovascular burden of individuals diagnosed with idiopathic hypersomnia: Real-World Idiopathic Hypersomnia
More news about: American Nutrition Association
Mar 24, 2026, 13:30 ET Plataforma LG ThinQ torna-se o centro da casa e unifica a rotina do lar
https://mma.prnewswire.com/media/2941395/image___2026_03_24T140202_182.jpg
More news about: LG Electronics Brasil
Mar 24, 2026, 13:19 ET OSCAR-NOMINATED VIVA VERDI! LAUNCHES IMPACT CAMPAIGN WITH SPECIAL SCREENINGS AT MOUNT SINAI AND NYU, BRIDGING ART, AGING, AND COMMUNITY
https://drive.google.com/drive/folders/1_qX-Mi3mi_pU5yy0T8qILYh_u82YF1tMWHEN/WHEREMarch 25, 6:30-8:30pm - New York University, Casa Italian Zerilli-MarmoFree:
More news about: VIVA VERDI!
Mar 24, 2026, 13:11 ET 同時進行紅血球沉降率 (ESR) 與 C 反應蛋白 (CRP) 檢測或可每年為醫院節省數百萬成本----新研究挑戰兩者可互相替代的觀念
然而，保留一項經過長期驗證、具臨床價值且每次僅需支付 2.70 美元的檢測，以協助避免不必要的跟進檢查，無疑是合理之舉。關於本研究引用：Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests."（結合紅血球沉降率與 C 反應蛋白檢測策略的經濟評估） ClinicoEconomics
More news about: Alcor Scientific
Mar 24, 2026, 13:04 ET El Club de Miembros de WATO: WATO reúne a los apasionados de las fiestas de disfraces de todo el mundo
enlacehttps://www.dropbox.com/t/jvNhsrRSNnu61ORyWATO te invita a Le Bal des Morts, la fiesta con temática funeraria más extravagante de tu vidaDiez años
More news about: WATO Members Club
Mar 24, 2026, 13:00 ET The 392 Roars Again: Dodge Brings Back the Legendary Durango R/T With More HEMI® Power Than Ever
New 2026 Dodge Durango R/T 392 Launch Edition delivers most horsepower in segment under $50,000For the first time ever, the legendary 392-cubic-inch V-8 HEMI® engine is standard on Durango R/TNew 2026 Dodge Durango R/T 392 Launch Edition pumps out 475 horsepower and
More news about: Stellantis
Mar 24, 2026, 12:46 ET /C O R R E C T I O N -- The Farmer's Dog/
/C O R R E C T I O N – The Farmer's Dog/ In the news release, The Farmer's Dog Brings Minimally Processed, Human-Grade Meal Plans to Walmart, Expanding Access for Dogs Nationwide, issued 24-Mar-2026 by The Farmer's Dog over PR Newswire, we are advised by the company that changes have been made.
More news about: The Farmer's Dog
Mar 24, 2026, 12:38 ET DRVN Shareholder Notice: Hagens Berman Notifies Driven Brands (DRVN) Investors to Securities Class Action Alleging Pervasive Accounting Errors and Internal Control Failures Spanning 2023-2025
www.youtube.com/watch?v=EwsGKJAAbdM&t=2sThe Driven Brands (DRVN) Securities Class Action: Pervasive Accounting ErrorsThe filed complaint in Clark
More news about: Hagens Berman Sobol Shapiro LLP
Mar 24, 2026, 12:01 ET Molten Salt Solutions Signs Strategic Agreements to Supply Enriched Lithium for Fusion Energy
as the companies conduct larger scale testing and deploy their first power plants."Enriched lithium is a key resource for enabling a closed D-T fusion fuel cycle and large-scale lithium enrichment is one of the anticipated bottlenecks for the deployment of fusion energy systems. Type One Energy
More news about: Molten Salt Solutions
Mar 24, 2026, 12:00 ET Maryland Center for History and Culture Reveals WayFinders: Making Sense of Our World, a New Hands-On Exhibition for Children and Families
making, gathering, and learning. The first-floor renovation includes updated restrooms, a nursing room, a public lunchroom, a classroom makerspace, the T. Rowe Price Community Gallery, and a refreshed France Hall Auditorium, expanding MCHC's ability to serve children, families, educators, and community
More news about: The Maryland Center for History and Culture
Mar 24, 2026, 11:56 ET Chrysler to Reveal Refreshed 2027 Pacifica at 2026 New York International Auto Show on April 1, 2026
Dodge Charger R/T is powered by the 3.0-liter, twin-turbocharged, SIXPACK standard-output (S.O.) engine, delivering 420 horsepower, 468. lb.-ft. of torque, a quarter-mile
More news about: Stellantis
Mar 24, 2026, 11:41 ET Analysts weigh benefits, risks associated with artificial intelligence at Quinnipiac University's Global Asset Management Education Forum XV
managing director of corporate strategy and head of client relations at Piedmont Fund Services. Mathieu Lorentz, director of engineering, AI solutions at T. Rowe Price, and Dillon Edwards, AI strategist and executive director at J.P. Morgan Asset Management, were the panelists.Asked directly at the
More news about: Quinnipiac University
Mar 24, 2026, 11:39 ET International Harrington Prize Jointly Awarded to Drs. Arul Chinnaiyan and Charles Sawyers
the treatment of high cholesterol.2019: Carl H. June, MD, University of Pennsylvania, for advancing the clinical application of CAR T therapy for cancer treatment, and for his sustained contributions to the field of cellular immunology.2020: Stuart H. Orkin, MD, Harvard University,
More news about: Harrington Discovery Institute
Mar 24, 2026, 11:05 ET Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
https://www.precedenceresearch.com/cell-and-gene-therapy-marketGrand View Research, CAR T-Cell Therapy Market — https://www.grandviewresearch.com/industry-analysis/car-t-cell-therapy-market-reportAstute Analytica, Regenerative
More news about: Equity Insider
Mar 24, 2026, 10:47 ET Fosun Pharma Announces 2025 Annual Results
for subsequent commercial growth. Additionally, 5 new innovative drugs were included in the 2025 National Reimbursement Drug List (NRDL), and the CAR-T therapy Yikaida (axicabtagene ciloleucel injection) was successfully listed in the first edition of the Commercial Insurance Innovative Drug Catalog.
More news about: Fosun Pharma